Document is current

Any future updates will be listed below

Galenus-Preis 2014: PDE-5-Hemmer Avanafil zählt zur Riege der Bewerber

Crossref DOI link: https://doi.org/10.1007/s00092-014-0660-3

Published Online: 2014-07-01

Published Print: 2014-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark